Compare EBON & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EBON | NAII |
|---|---|---|
| Founded | 2010 | 1980 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 21.2M |
| IPO Year | 2020 | 1987 |
| Metric | EBON | NAII |
|---|---|---|
| Price | $3.50 | $3.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 34.0K |
| Earning Date | 08-15-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,337,066.00 | ★ $134,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 104.28 | 19.00 |
| 52 Week Low | $3.00 | $2.57 |
| 52 Week High | $9.61 | $4.70 |
| Indicator | EBON | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 61.05 |
| Support Level | $3.37 | $3.45 |
| Resistance Level | $3.70 | $3.70 |
| Average True Range (ATR) | 0.25 | 0.23 |
| MACD | 0.00 | 0.05 |
| Stochastic Oscillator | 20.84 | 77.42 |
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.